original_dataset
stringclasses 7
values | instance_id
stringlengths 5
33
| phrase
stringlengths 1
166
| meddra_code
float64 10M
10.1M
⌀ | sct_id
float64 1.4M
571B
⌀ | umls_cui
stringlengths 8
8
⌀ | mapped_meddra_codes
stringlengths 8
62
| mapped_sct_ids
stringlengths 6
66
| single_mapped_meddra_codes
int64 10M
10.1M
| single_mapped_sct_ids
int64 450k
281,801B
|
|---|---|---|---|---|---|---|---|---|---|
TAC2017_ADR
|
DUREZOL.xml_AR25.N1
|
increased lacrimation
| 10,023,644 | null | null |
10023644
|
193982009 418035005
| 10,023,644 | 418,035,005 |
TAC2017_ADR
|
DUREZOL.xml_AR26.N1
|
macular edema
| 10,025,415 | null | null |
10025415 10058202
|
193387007 37231002
| 10,058,202 | 193,387,007 |
TAC2017_ADR
|
DUREZOL.xml_AR27.N1
|
sclera hyperemia
| 10,059,096 | null | null |
10059096
|
246980005
| 10,059,096 | 246,980,005 |
TAC2017_ADR
|
DUREZOL.xml_AR28.N1
|
uveitis
| 10,046,851 | null | null |
10046851
|
128473001
| 10,046,851 | 128,473,001 |
TAC2017_ADR
|
DUREZOL.xml_AR29.N1
|
blurred vision
| 10,047,513 | null | null |
10047513
|
111516008 246636008
| 10,047,513 | 246,636,008 |
TAC2017_ADR
|
DUREZOL.xml_AR31.N1
|
headache
| 10,019,211 | null | null |
10019211
|
25064002
| 10,019,211 | 25,064,002 |
TAC2017_ADR
|
DUREZOL.xml_AR32.N1
|
increased iop
| 10,022,806 | null | null |
10022806
|
112222000
| 10,022,806 | 112,222,000 |
TAC2017_ADR
|
DUREZOL.xml_AR34.N1
|
dry eye
| 10,013,774 | null | null |
10013774
|
162290004
| 10,013,774 | 162,290,004 |
TAC2017_ADR
|
DUREZOL.xml_AR35.N1
|
iridocyclitis
| 10,022,941 | null | null |
10022941
|
77971008
| 10,022,941 | 77,971,008 |
TAC2017_ADR
|
DUREZOL.xml_AR36.N1
|
intraocular pressure increase
| 10,022,806 | null | null |
10022806
|
112222000
| 10,022,806 | 112,222,000 |
TAC2017_ADR
|
DUREZOL.xml_AR37.N1
|
iop increase
| 10,022,806 | null | null |
10022806
|
112222000
| 10,022,806 | 112,222,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR3.N1
|
interstitial lung disease
| 10,022,611 | null | null |
10022611
|
233703007
| 10,022,611 | 233,703,007 |
TAC2017_ADR
|
ZYKADIA.xml_AR4.N1
|
pneumonitis
| 10,035,742 | null | null |
10035742
|
205237003
| 10,035,742 | 205,237,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR5.N1
|
qt interval prolongation
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR6.N1
|
hyperglycemia
| 10,020,635 | null | null |
10020635
|
237598005 80394007
| 10,020,635 | 80,394,007 |
TAC2017_ADR
|
ZYKADIA.xml_AR7.N1
|
bradycardia
| 10,006,093 | null | null |
10019301 10006093
|
48867003
| 10,006,093 | 48,867,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR8.N1
|
pancreatitis
| 10,033,645 | null | null |
10033645
|
75694006
| 10,033,645 | 75,694,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR9.N1
|
diarrhea
| 10,012,735 | null | null |
10012735
|
267060006 62315008
| 10,012,735 | 62,315,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR10.N1
|
nausea
| 10,028,813 | null | null |
10028813
|
422587007
| 10,028,813 | 422,587,007 |
TAC2017_ADR
|
ZYKADIA.xml_AR12.N1
|
vomiting
| 10,047,700 | null | null |
10047700
|
249497008 422400008
| 10,047,700 | 422,400,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR13.N1
|
abdominal pain
| 10,000,081 | null | null |
10000081 10017999
|
21522001
| 10,000,081 | 21,522,001 |
TAC2017_ADR
|
ZYKADIA.xml_AR14.N1
|
fatigue
| 10,016,256 | null | null |
10016256 10003549
|
248274002 84229001 13791008
| 10,016,256 | 84,229,001 |
TAC2017_ADR
|
ZYKADIA.xml_AR15.N1
|
decreased appetite
| 10,061,428 | null | null |
10061428
|
64379006
| 10,061,428 | 64,379,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR16.N1
|
constipation
| 10,010,774 | null | null |
10010774
|
14760008
| 10,010,774 | 14,760,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR19.N1
|
convulsion
| 10,039,906 | null | null |
10039906
|
91175000
| 10,039,906 | 91,175,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR20.N1
|
pneumonia
| 10,035,664 | null | null |
10035742 10035664
|
233604007
| 10,035,664 | 233,604,007 |
TAC2017_ADR
|
ZYKADIA.xml_AR21.N1
|
ild
| 10,022,611 | null | null |
10022611
|
233703007
| 10,022,611 | 233,703,007 |
TAC2017_ADR
|
ZYKADIA.xml_AR22.N1
|
dyspnea
| 10,013,968 | null | null |
10013968
|
230145002 267036007
| 10,013,968 | 267,036,007 |
TAC2017_ADR
|
ZYKADIA.xml_AR23.N1
|
dehydration
| 10,012,174 | null | null |
10012174
|
34095006
| 10,012,174 | 34,095,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR24.N1
|
fatal
| 10,011,906 | null | null |
10011906
|
397709008 268923008
| 10,011,906 | 397,709,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR25.N1
|
respiratory failure
| 10,038,695 | null | null |
10038695
|
409622000
| 10,038,695 | 409,622,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR26.N1
|
pneumothorax
| 10,035,759 | null | null |
10035759
|
36118008
| 10,035,759 | 36,118,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR27.N1
|
gastric hemorrhage
| 10,017,788 | null | null |
10017788
|
61401005
| 10,017,788 | 61,401,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR29.N1
|
pulmonary tuberculosis
| 10,037,440 | null | null |
10037440
|
154283005
| 10,037,440 | 154,283,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR30.N1
|
cardiac tamponade
| 10,007,610 | null | null |
10007610
|
35304003
| 10,007,610 | 35,304,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR31.N1
|
sepsis
| 10,040,047 | null | null |
10040047 10077116
|
91302008
| 10,040,047 | 91,302,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR32.N1
|
upper abdominal pain
| 10,000,087 | null | null |
10000087
|
83132003
| 10,000,087 | 83,132,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR33.N1
|
abdominal discomfort
| 10,000,059 | null | null |
10000059
|
43364001
| 10,000,059 | 43,364,001 |
TAC2017_ADR
|
ZYKADIA.xml_AR34.N1
|
epigastric discomfort
| 10,053,155 | null | null |
10053155
|
119416008
| 10,053,155 | 119,416,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR35.N1
|
esophageal disorder
| 10,061,318 | null | null |
10061318
|
37657006
| 10,061,318 | 37,657,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR36.N1
|
dyspepsia
| 10,013,946 | null | null |
10013946
|
162031009
| 10,013,946 | 162,031,009 |
TAC2017_ADR
|
ZYKADIA.xml_AR37.N1
|
gastroesophageal reflux disease
| 10,017,885 | null | null |
10017885
|
235595009 698065002
| 10,017,885 | 235,595,009 |
TAC2017_ADR
|
ZYKADIA.xml_AR38.N1
|
dysphagia
| 10,013,950 | null | null |
10013950
|
40739000 288939007
| 10,013,950 | 40,739,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR39.N1
|
asthenia
| 10,003,549 | null | null |
10003549
|
13791008
| 10,003,549 | 13,791,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR40.N1
|
rash
| 10,037,844 | null | null |
10037844
|
271807003
| 10,037,844 | 271,807,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR41.N1
|
maculopapular rash
| 10,037,868 | null | null |
10037868
|
247471006
| 10,037,868 | 247,471,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR43.N1
|
neuropathy
| 10,029,331 | null | null |
10029331
|
386033004 302226006
| 10,029,331 | 302,226,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR44.N1
|
paresthesia
| 10,033,775 | null | null |
10033775
|
91019004
| 10,033,775 | 91,019,004 |
TAC2017_ADR
|
ZYKADIA.xml_AR45.N1
|
muscular weakness
| 10,028,372 | null | null |
10028372
|
26544005
| 10,028,372 | 26,544,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR46.N1
|
gait disturbance
| 10,017,577 | null | null |
10017577
|
22325002
| 10,017,577 | 22,325,002 |
TAC2017_ADR
|
ZYKADIA.xml_AR47.N1
|
peripheral neuropathy
| 10,029,331 | null | null |
10029331
|
302226006
| 10,029,331 | 302,226,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR48.N1
|
hypoesthesia
| 10,020,937 | null | null |
10020937
|
59073000
| 10,020,937 | 59,073,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR49.N1
|
peripheral sensory neuropathy
| 10,034,620 | null | null |
10034620
|
95662005
| 10,034,620 | 95,662,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR50.N1
|
dysesthesia
| 10,013,886 | null | null |
10013886
|
279079003
| 10,013,886 | 279,079,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR51.N1
|
neuralgia
| 10,029,223 | null | null |
10029223
|
16269008
| 10,029,223 | 16,269,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR52.N1
|
peripheral motor neuropathy
| 10,034,580 | null | null |
10034580 10029331
|
95663000 128192007
| 10,034,580 | 95,663,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR53.N1
|
hypotonia
| 10,021,118 | null | null |
10021118 10058909
|
398152000 398151007
| 10,021,118 | 398,152,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR54.N1
|
polyneuropathy
| 10,036,105 | null | null |
10036105
|
42345000
| 10,036,105 | 42,345,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR56.N1
|
vision impairment
| 10,047,571 | null | null |
10047571
|
397540003 7973008
| 10,047,571 | 397,540,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR57.N1
|
blurred vision
| 10,047,513 | null | null |
10047513
|
111516008 246636008
| 10,047,513 | 246,636,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR58.N1
|
photopsia
| 10,034,962 | null | null |
10034962
|
56170001
| 10,034,962 | 56,170,001 |
TAC2017_ADR
|
ZYKADIA.xml_AR59.N1
|
accommodation disorder
| 10,000,389 | null | null |
10000389
|
54552008
| 10,000,389 | 54,552,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR60.N1
|
presbyopia
| 10,036,628 | null | null |
10036628
|
41256004
| 10,036,628 | 41,256,004 |
TAC2017_ADR
|
ZYKADIA.xml_AR61.N1
|
reduced visual acuity
| 10,047,531 | null | null |
10047531
|
13164000
| 10,047,531 | 13,164,000 |
TAC2017_ADR
|
ZYKADIA.xml_AR62.N1
|
prolonged qt interval
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR63.N1
|
hemoglobin decreased
| 10,018,884 | null | null |
10018884
|
165397008
| 10,018,884 | 165,397,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR72.N1
|
bilirubin total increased
| 10,005,364 | null | null |
10005364
|
26165005 176271000119108
| 10,005,364 | 26,165,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR73.N1
|
qtc interval prolongation
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR79.N1
|
jaundice
| 10,023,126 | null | null |
10023126
|
18165001
| 10,023,126 | 18,165,001 |
TAC2017_ADR
|
ZYKADIA.xml_AR81.N1
|
total bilirubin 2 times the uln
| 10,005,364 | null | null |
10005364
|
26165005
| 10,005,364 | 26,165,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR82.N1
|
ventricular tachyarrhythmias
| 10,065,341 | null | null |
10065341 10047302
|
25569003
| 10,065,341 | 25,569,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR83.N1
|
torsade de pointes
| 10,044,066 | null | null |
10044066
|
31722008
| 10,044,066 | 31,722,008 |
TAC2017_ADR
|
ZYKADIA.xml_AR85.N1
|
qtc interval increase
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR86.N1
|
qtc greater than 500 msec
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR87.N1
|
increase from baseline qtc
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR88.N1
|
increases in the qtc interval
| 10,014,387 | null | null |
10014387
|
111975006
| 10,014,387 | 111,975,006 |
TAC2017_ADR
|
ZYKADIA.xml_AR89.N1
|
sinus bradycardia
| 10,040,741 | null | null |
10040741
|
49710005
| 10,040,741 | 49,710,005 |
TAC2017_ADR
|
ZYKADIA.xml_AR90.N1
|
heart rate of less than 50 beats per minute
| 10,019,301 | null | null |
10019301 10006093
|
48867003
| 10,019,301 | 48,867,003 |
TAC2017_ADR
|
ZYKADIA.xml_AR91.N1
|
fatality
| 10,011,906 | null | null |
10011906
|
397709008 268923008
| 10,011,906 | 397,709,008 |
TAC2017_ADR
|
CHOLINE.xml_AR1.N1
|
injection site reaction
| 10,022,095 | null | null |
10022095
|
95377006
| 10,022,095 | 95,377,006 |
TAC2017_ADR
|
CHOLINE.xml_AR2.N1
|
allergic reactions
| 10,020,751 | null | null |
10020751
|
418634005
| 10,020,751 | 418,634,005 |
TAC2017_ADR
|
CHOLINE.xml_AR4.N1
|
anaphylaxis
| 10,002,198 | null | null |
10002198 10002199
|
39579001
| 10,002,198 | 39,579,001 |
TAC2017_ADR
|
CHOLINE.xml_AR5.N1
|
cancer
| 10,028,997 | null | null |
10028997
|
363346000
| 10,028,997 | 363,346,000 |
TAC2017_ADR
|
ERWINAZE.xml_AR1.N1
|
hypersensitivity reactions
| 10,020,751 | null | null |
10020751
|
418634005
| 10,020,751 | 418,634,005 |
TAC2017_ADR
|
ERWINAZE.xml_AR2.N1
|
pancreatitis
| 10,033,645 | null | null |
10033645
|
75694006
| 10,033,645 | 75,694,006 |
TAC2017_ADR
|
ERWINAZE.xml_AR3.N1
|
glucose intolerance
| 10,018,429 | null | null |
10018429
|
267426009 9414007
| 10,018,429 | 9,414,007 |
TAC2017_ADR
|
ERWINAZE.xml_AR4.N1
|
thrombosis
| 10,043,607 | null | null |
10043607
|
439127006
| 10,043,607 | 439,127,006 |
TAC2017_ADR
|
ERWINAZE.xml_AR5.N1
|
hemorrhage
| 10,055,798 | null | null |
10015867 10055798
|
131148009
| 10,055,798 | 131,148,009 |
TAC2017_ADR
|
ERWINAZE.xml_AR6.N1
|
systemic hypersensitivity
| 10,020,751 | null | null |
10020751
|
418634005
| 10,020,751 | 418,634,005 |
TAC2017_ADR
|
ERWINAZE.xml_AR7.N1
|
hyperglycemia
| 10,020,635 | null | null |
10020635
|
237598005 80394007
| 10,020,635 | 80,394,007 |
TAC2017_ADR
|
ERWINAZE.xml_AR9.N1
|
fever
| 10,037,660 | null | null |
10037660 10020843 10005911
|
386661006
| 10,037,660 | 386,661,006 |
TAC2017_ADR
|
ERWINAZE.xml_AR11.N1
|
vomiting
| 10,047,700 | null | null |
10047700
|
249497008 422400008
| 10,047,700 | 422,400,008 |
TAC2017_ADR
|
ERWINAZE.xml_AR12.N1
|
nausea
| 10,028,813 | null | null |
10028813
|
422587007
| 10,028,813 | 422,587,007 |
TAC2017_ADR
|
ERWINAZE.xml_AR13.N1
|
hyperbilirubinemia
| 10,020,578 | null | null |
10020578
|
14783006 166612004
| 10,020,578 | 14,783,006 |
TAC2017_ADR
|
ERWINAZE.xml_AR14.N1
|
abdominal pain
| 10,000,081 | null | null |
10000081 10017999
|
21522001
| 10,000,081 | 21,522,001 |
TAC2017_ADR
|
ERWINAZE.xml_AR15.N1
|
abdominal discomfort
| 10,000,059 | null | null |
10000059
|
43364001
| 10,000,059 | 43,364,001 |
TAC2017_ADR
|
ERWINAZE.xml_AR16.N1
|
diarrhea
| 10,012,735 | null | null |
10012735
|
267060006 62315008
| 10,012,735 | 62,315,008 |
TAC2017_ADR
|
ERWINAZE.xml_AR17.N1
|
allergic reactions
| 10,020,751 | null | null |
10020751
|
418634005
| 10,020,751 | 418,634,005 |
TAC2017_ADR
|
ERWINAZE.xml_AR18.N1
|
allergy
| 10,020,751 | null | null |
10013700
|
416098002 416093006
| 10,013,700 | 416,098,002 |
TAC2017_ADR
|
ERWINAZE.xml_AR19.N1
|
coagulopathy
| 10,009,802 | null | null |
10009802 10019009
|
64779008
| 10,009,802 | 64,779,008 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.